This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


peer-reviewed publication


COVID-19 vaccination appears safe in study of patients with glomerular diseases

COVID-19 vaccine
Credit: Unsplash/CC0 Public Domain

Among 2,055 adults with a wide range of glomerular diseases, the COVID-19 vaccination did not adversely affect kidney function or worsen kidney damage and appeared safe in this population, according to a study published in the American Journal of Kidney Diseases (AJKD).

Patients with glomerular disease (GN) may be at increased risk of severe COVID-19, yet concerns over vaccines causing disease relapse may lead to vaccine hesitancy.

Researchers examined the associations of COVID-19 with longitudinal and proteinuria and compared these to similar associations with COVID-19 vaccination.

In this cohort study of 2,055 patients with minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), membranous nephropathy, or IgA nephropathy (IgAN), COVID-19 resulted in hospitalization or death for one in eight cases and was associated with a 35% increase in risk for worsening proteinuria.

In contrast, vaccination did not appear to adversely affect kidney function or proteinuria. The data in this study support vaccination for COVID-19 in patients with glomerular disease.

More information: Chia-shi Wang et al, Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study, American Journal of Kidney Diseases (2023). DOI: 10.1053/j.ajkd.2023.07.008

Provided by National Kidney Foundation
Citation: COVID-19 vaccination appears safe in study of patients with glomerular diseases (2023, September 6) retrieved 4 March 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Population-level study provides reassuring data on the risk of kidney disease relapse after COVID-19 vaccination


Feedback to editors